跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Natripine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Natripine
Approved
STANDARD
Natripine
Aju Pharma Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0e5fc6ce92108119
Company
Aju Pharma Co., Ltd.
Type
Standard
Approval Details
Approval Id
0e5fc6ce92108119
Drug Approval Philippines Name
Natripine
Product Name
Natripine
Registration Number
DRP-8442
Brand Name
Natripine
Generic Name
Nicardipine Hydrochloride
Dosage Form
Solution For Injection (IV)
Dosage Strength
1mg/Ml (10 mg/10 mL)
Manufacturer
Aju Pharma Co., Ltd.
Importer
Triple Tact Import & Export Corp.,
Distributor
Triple Tact Import & Export Corp.,
Issuance Date
24 September 2022
Expiry Date
24 November 2027
Pharmacologic Category
Calcium Channel Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0e5fc6ce92108119
Type
Standard
Back to Philippines FDA Approvals